2026-01-26 - Analysis Report
**Company Overview**
Northrop Grumman Corporation is a leading global aerospace and defense technology company.

**Comparison of Return Rates**

* Cumulative return of review stock (NOC): 118.49%
* Cumulative return of comparison stock (S&P 500, VOO): 126.41%
* Divergence (max: 54.00, min: -64.70, current: -8.00, relative divergence: 47.80%)

NOC's cumulative return is about 8.00% lower than the comparison stock (VOO) as of the last available data.

**Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 0.0% | 24.8% | -12.0% | 0.7 | 35.1B |
| 2017-2019  | 25.0% | 24.8% | 0.0% | 0.7 | 49.2B |
| 2018-2020  | -32.0% | 27.2% | -57.0% | 0.8 | 43.6B |
| 2019-2021  | 32.0% | 27.2% | -34.0% | 0.7 | 55.4B |
| 2020-2022  | 45.0% | 25.9% | 39.0% | 0.6 | 78.1B |
| 2021-2023  | 50.0% | 19.7% | 30.0% | 0.3 | 67.0B |
| 2022-2024  | 19.0% | 19.7% | -10.0% | 0.3 | 67.2B |
| 2023-2025  | 27.0% | 18.4% | -48.0% | 0.1 | 81.6B |

The Alpha (0.0% to 39.0%) and Beta (0.1 to 0.8) show varying levels of performance over different periods.

**Recent Stock Price Fluctuations**

* Close: $672.95
* Last-market: $672.95 (0.37% increase)
* 5-day SMA: $666.35
* 20-day SMA: $618.54
* 60-day SMA: $583.71

The stock has been relatively stable in the short term, with a minor increase.

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence**

* Market Risk Indicator (MRI): 0.70 (Medium Investment)
* RSI: 73.88
* PPO: 0.86
* Hybrid Signal: Buy (Cash 0%)
* Recent (20 days) relative divergence change: 5.80 (+) improving
* 7-day Rank change: 0 (0): flat
* 7-day Dynamic Expected Return change: 0.00 (0): flat
* Expected Return (%): -13.10% Expected excess return compared to S&P 500 if invested long-term

The current risk level is medium, with a slight improvement in relative divergence.

**Recent News & Significant Events**

* [2026-01-25] Northrop Grumman Corporation $NOC Shares Sold by Strs Ohio - MarketBeat (news.google.com)
* [2026-01-21] Is It Too Late To Consider Northrop Grumman (NOC) After Strong Multi‑Year Share Gains? - Yahoo Finance (news.google.com)
* [2026-01-21] If You Invested $100 In Northrop Grumman Stock 5 Years Ago, You Would Have This Much Today - Sahm (news.google.com)
* [2026-01-08] What’s The Risk For Northrop Grumman Stock As Trump Curbs Dividends And Executive Pay? - Forbes (news.google.com)
* [2026-01-23] How New Navy Torpedo Deals And MUX Win At Northrop Grumman (NOC) Has Changed Its Investment Story - simplywall.st (news.google.com)
* [2026-01-08] With Northrop Grumman Stock Sliding, Have You Assessed The Risk? - Trefis (news.google.com)

Several recent news articles discuss Northrop Grumman's stock performance, investment risks, and strategic developments.

**Analyst Opinions**

* Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 2.17 (~Buy)
  - Opinions: 21
  - Target Price (avg/high/low): $680.44 / $777.00 / $576.00

Analysts generally recommend investing in NOC with a strong buy consensus and a mean rating of 2.17.

**Recent Earnings Analysis**

| Date | EPS | Revenue |
|----|---:|-----:|
| 2025-10-21 | 7.69 | $10.42 B$ |
| 2025-07-22 | 8.17 | $10.35 B$ |
| 2025-04-22 | 3.33 | $9.47 B$ |
| 2024-10-24 | 7.02 | $10.00 B$ |
| 2025-10-21 | 7.02 | $10.00 B$ |

Northrop Grumman's earnings per share (EPS) have fluctuated between $3.33 and $8.17, while revenue has remained relatively stable around $10 billion.

**Financial Information = 5. Financial Information**

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $10.42B | 21.37% |
| 2025-06-30 | $10.35B | 21.35% |
| 2025-03-31 | $9.47B | 16.69% |
| 2024-12-31 | $10.69B | 18.08% |
| 2024-09-30 | $10.00B | 21.07% |

Northrop Grumman's revenue has been relatively stable, with fluctuations in profit margin.

**Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $15.99B | 6.88% |
| 2025-06-30 | $15.47B | 7.59% |
| 2025-03-31 | $14.98B | 3.21% |
| 2024-12-31 | $15.29B | 8.27% |
| 2024-09-30 | $14.75B | 6.96% |

The company's equity has fluctuated, with varying returns on equity (ROE).

**Comprehensive Analysis (Summary of previous items)**

Northrop Grumman's cumulative return is slightly lower than the comparison stock (VOO). The company's Alpha and Beta show varying levels of performance over different periods. The stock has been relatively stable in the short term. The current risk level is medium, with a slight improvement in relative divergence. Analysts generally recommend investing in NOC with a strong buy consensus and a mean rating of 2.17. The company's earnings per share (EPS) have fluctuated between $3.33 and $8.17, while revenue has remained relatively stable around $10 billion. The company's equity has fluctuated, with varying returns on equity (ROE).

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.